Clinical Trials Logo
  1. Home
  2. Severe Aortic Valve Stenosis
  3. NCT05552352

VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease — VRAP-Heart  

Severe Aortic Valve Stenosis Clinical Trial

Official title:
VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease - A Randomized-Controlled Multicenter Study

Clinical Trial Summary

This prospective, randomized-controlled multicenter study investigates whether virtual reality-assisted patient education in patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) can improve patient understanding and simulative orientation, thereby reducing postinterventional complications, resulting in significantly shorter length of stay.

Clinical Trial Description

This prospective, randomized-controlled multicenter study investigates whether VR-assisted patient education in patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) can improve patient understanding and simulative orientation, thereby reducing postinterventional complications, resulting in significantly shorter length of stay. Disorientation, anxiety, and pain can lead to the development of delirium and, through complications, to prolonged hospital stays during elective procedures. Virtual reality can combine different learning modalities (auditory, visual, written, haptic) and improve patient understanding of the procedure through educational interventions. More detailed knowledge of the environment, the players, the procedure, and safety aspects will reduce anxiety and stress before and during the procedure and reduce complications during post-interventional care. As a result, length of stay should be reduced. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05552352
Study type Interventional
Source Heinrich-Heine University, Duesseldorf
Contact Christian Jung, Prof MD PhD
Phone +49 211 81
Email christian.jung@med.uni-duesseldorf.de
Status Recruiting
Phase N/A
Start date October 5, 2022
Completion date May 31, 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT06168123 - Future Optimal Research and Care Evaluation - Aortic Stenosis
Active, not recruiting NCT05182307 - DurAVR™ THV System: First-In-Human Study N/A
Recruiting NCT06156592 - Post Spinal Hemodynamic Changes in Aortic Stenosis and Mitral Regurgitation by VIS Index and Echocardiography
Completed NCT04259723 - Virtual Reality Assisted Conscious Sedation During TAVI N/A
Recruiting NCT05873816 - The PROTEMBO Trial N/A
Recruiting NCT04128384 - Infranodal Conduction Time During TAVR as Predictor of HAVB N/A
Recruiting NCT05024942 - LUS in Aortic Stenosis Patients Undergoing TAVR
Recruiting NCT05283356 - Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation Phase 4
Not yet recruiting NCT05847751 - The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis
Completed NCT02224066 - Platelet Reactivity After TAVI: A Multicenter Pilot Study Phase 4
Recruiting NCT06168370 - Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation N/A
Recruiting NCT05097183 - Validation of Accurate Commissural Alignment During Transcatheter Aortic Valve Implantation
Active, not recruiting NCT05712161 - Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study N/A
Not yet recruiting NCT04988243 - Multi Center Registry of Transcatheter Aortic Valve Replacement in Northeast China N/A